We are live on ! Find out more
VXRT

Vaxart
VXRT

Delisted

VXRT was delisted on the 7th of July, 2025.

Back to rankings

58 hedge funds and large institutions have $34.6M invested in Vaxart in 2014 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 16 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 16

8% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 12

2% less funds holding

Funds holding: 59 → 58 (-1)

55% less capital invested

Capital invested by funds: $77.3M → $34.6M (-$42.7M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $516K

Holders
58
Holders Change
-1
Holders Change %
-1.69%
% of All Funds
1.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
18
Reduced
16
Closed
12
Calls
–
Puts
$516K
Net Calls
-$516K
Net Calls Change
-$341K

Top Buyers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
+$1.84M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$1.29M
3
Goldman Sachs
Goldman Sachs
New York
+$453K
4
California Public Employees Retirement System
California Public Employees Retirement System
California
+$441K
5
BIT
BlackRock Institutional Trust
California
+$387K

Top Sellers

Rank Fund Capital Flow
1
HM
HealthCor Management
New York
-$7.03M
2
6CM
683 Capital Management
New York
-$1.05M
3
TC
TFS Capital
Pennsylvania
-$646K
4
PA
Perceptive Advisors
New York
-$614K
5
U
UBS
Switzerland
-$515K
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
51
Barclays
United Kingdom
$9K +$16.3K +391 +4,344%
Manulife (Manufacturers Life Insurance)
52
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$8K -$125 -3 -1%
NFA
53
Nationwide Fund Advisors
Ohio
$6K +$7.98K +191 New
Bank of America
54
Bank of America
North Carolina
$2K +$2.42K +58 New
AIG
55
American International Group
New York
$285 – – –
BNP Paribas Financial Markets
56
BNP Paribas Financial Markets
France
$182 – – –
HM
57
HealthCor Management
New York
– -$7.03M -104,545 Closed
6CM
58
683 Capital Management
New York
– -$1.05M -15,662 Closed
U
59
UBS
Switzerland
– -$515K -7,657 Closed
Citadel Advisors
60
Citadel Advisors
Florida
– -$438K -6,523 Closed
PAM
61
Panagora Asset Management
Massachusetts
– -$370K -5,500 Closed
BCMU
62
BlueCrest Capital Management (UK)
Guernsey
– -$249K -3,700 Closed
SFM
63
Soros Fund Management
New York
– -$241K -3,591 Closed
LP
64
LMR Partners
United Kingdom
– -$182K -2,720 Closed
Connor, Clark & Lunn Investment Management (CC&L)
65
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$129K -1,745 Closed
Wells Fargo
66
Wells Fargo
California
– -$61.8K -1,480 -99%
N
67
Natixis
France
– -$96K -1,427 Closed
Bank of Montreal
68
Bank of Montreal
Ontario, Canada
– -$81K -1,211 Closed
TRCT
69
Tower Research Capital (TRC)
New York
– -$10K -142 Closed
1 2
3

VXRT Hedge Fund Activity: Q2 2014 in Review

58 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q2 2014, worth a combined $34.6M — down 55% from $77.3M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of VXRT and 11 opened new positions — a net loss of 1 holder — while 16 trimmed existing stakes and 18 added.

The largest buyer was Broadfin Capital, adding an estimated $1.84M. The largest seller was HealthCor Management, exiting entirely with an estimated $7.03M sold.

  • 58 institutional investors held Vaxart (VXRT) as of Q2 2014, down from 59 in Q1 2014.
  • Funds reported $34.6M of Vaxart stock for Q2 2014, down 55% quarter-over-quarter.
  • 11 funds opened new Vaxart positions in Q2 2014 and 12 closed out, a net change of -1 holder.
  • The largest Vaxart buyer in Q2 2014 was Broadfin Capital, an estimated $1.84M added.
  • The largest Vaxart seller in Q2 2014 was HealthCor Management, an estimated $7.03M sold.

Based on aggregated 13F filings for Q2 2014.